{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T06:11:05Z","timestamp":1772777465536,"version":"3.50.1"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,10,15]],"date-time":"2021-10-15T00:00:00Z","timestamp":1634256000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,10,15]],"date-time":"2021-10-15T00:00:00Z","timestamp":1634256000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100000069","name":"National Institute of Arthritis and Musculoskeletal and Skin Diseases","doi-asserted-by":"publisher","award":["K23AR067889"],"award-info":[{"award-number":["K23AR067889"]}],"id":[{"id":"10.13039\/100000069","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["I01 CX001183"],"award-info":[{"award-number":["I01 CX001183"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000738","name":"U.S. Department of Veterans Affairs","doi-asserted-by":"publisher","award":["IK6 HX002608-01"],"award-info":[{"award-number":["IK6 HX002608-01"]}],"id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Rheumatol"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>We describe Raynauds phenomenon (RP), potential very early diagnosis of systemic sclerosis (VEDOSS), and systemic sclerosis (SSc) in Veterans deployed in support of Post-9\/11 operations. We sought to describe the military occupation specialty, clinical features, and vasodilator use across the three diagnoses.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Individual Veterans medical records were assessed for RP (ICD-9443.0), VEDOSS with swelling of hands (ICD-9729.81) and RP (ICD-9443.0), and SSc (ICD-9710.1). The distribution of sociodemographic, military service branch, job classification, vasodilator use, and comorbidities were examined across the three classifications of disease. The chi-squared test and Fisher\u2019s exact compared frequency of these categorical variables. Logistic regression assessed the likelihood of characteristics of the three classifications.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>In this population of 607,665 individual Veteran medical records, 857 had RP, 45 met possible VEDOSS criteria, and 71 had a diagnosis of SSc. The majority of RP, potential VEDOSS and SSc cases were white males. Those in craftworks, engineering or maintenance, and healthcare had a greater likelihood of RP. Less than half of RP and VEDOSS patients were on vasodilators. The most common comorbidities in this population were the diagnostic code for pain (highest in the potential VEDOSS group [81.6%]), followed by depression in all groups.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>This is a unique Veteran population of predominately-male patients. Our data suggests that vasodilator medications are potentially being under-utilized for RP and potential VEDOSS. Our data highlights mood and pain management as an important aspect of SSc care.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s41927-021-00209-z","type":"journal-article","created":{"date-parts":[[2021,10,15]],"date-time":"2021-10-15T09:45:15Z","timestamp":1634291115000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["The frequency of Raynaud\u2019s phenomenon, very early diagnosis of systemic sclerosis, and systemic sclerosis in a large Veteran Health Administration database"],"prefix":"10.1186","volume":"5","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5472-3840","authenticated-orcid":false,"given":"Tracy M.","family":"Frech","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maureen A.","family":"Murtaugh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Megan","family":"Amuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary Jo","family":"Pugh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,10,15]]},"reference":[{"issue":"6","key":"209_CR1","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1056\/NEJMra1507638","volume":"375","author":"FM Wigley","year":"2016","unstructured":"Wigley FM, Flavahan NA. Raynaud's phenomenon. N Engl J Med. 2016;375(6):556\u201365. https:\/\/doi.org\/10.1056\/NEJMra1507638.","journal-title":"N Engl J Med"},{"issue":"2","key":"209_CR2","first-page":"123","volume":"113","author":"KK Temprano","year":"2016","unstructured":"Temprano KK. A review of Raynaud's disease. Mo Med. 2016;113(2):123\u20136.","journal-title":"Mo Med"},{"key":"209_CR3","doi-asserted-by":"publisher","unstructured":"Herrick A. Raynaud's Phenomenon. J Scleroderma Relat Disord. 2019;4(2):89\u2013101. https:\/\/doi.org\/10.1177\/2397198319826467.","DOI":"10.1177\/2397198319826467"},{"issue":"2","key":"209_CR4","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1002\/art.24284","volume":"61","author":"M Hudson","year":"2009","unstructured":"Hudson M, Thombs B, Baron M. Canadian scleroderma research G. time to diagnosis in systemic sclerosis: is sex a factor? Arthritis Rheum. 2009;61(2):274\u20138. https:\/\/doi.org\/10.1002\/art.24284.","journal-title":"Arthritis Rheum"},{"issue":"4","key":"209_CR5","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/j.clindermatol.2018.04.007","volume":"36","author":"T Stringer","year":"2018","unstructured":"Stringer T, Femia AN. Raynaud's phenomenon: current concepts. Clin Dermatol. 2018;36(4):498\u2013507. https:\/\/doi.org\/10.1016\/j.clindermatol.2018.04.007.","journal-title":"Clin Dermatol"},{"issue":"10","key":"209_CR6","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s11926-017-0684-2","volume":"19","author":"S Bellando-Randone","year":"2017","unstructured":"Bellando-Randone S, Matucci-Cerinic M. Very early systemic sclerosis and pre-systemic sclerosis: definition, recognition, clinical relevance and future directions. Curr Rheumatol Rep. 2017;19(10):65. https:\/\/doi.org\/10.1007\/s11926-017-0684-2.","journal-title":"Curr Rheumatol Rep"},{"issue":"4","key":"209_CR7","doi-asserted-by":"publisher","first-page":"245","DOI":"10.2174\/157339710904140417124819","volume":"9","author":"S Bellando-Randone","year":"2013","unstructured":"Bellando-Randone S, Matucci-Cerinic M. From Raynaud's phenomenon to very early diagnosis of systemic sclerosis- the VEDOSS approach. Curr Rheumatol Rev. 2013;9(4):245\u20138. https:\/\/doi.org\/10.2174\/157339710904140417124819.","journal-title":"Curr Rheumatol Rev"},{"issue":"1","key":"209_CR8","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1136\/annrheumdis-2013-203889","volume":"74","author":"G Lepri","year":"2015","unstructured":"Lepri G, Guiducci S, Bellando-Randone S, Giani I, Bruni C, Blagojevic J, et al. Evidence for oesophageal and anorectal involvement in very early systemic sclerosis (VEDOSS): report from a single VEDOSS\/EUSTAR Centre. Ann Rheum Dis. 2015;74(1):124\u20138. https:\/\/doi.org\/10.1136\/annrheumdis-2013-203889.","journal-title":"Ann Rheum Dis"},{"key":"209_CR9","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1016\/j.compbiomed.2014.07.022","volume":"53","author":"D Redd","year":"2014","unstructured":"Redd D, Frech TM, Murtaugh MA, Rhiannon J, Zeng QT. Informatics can identify systemic sclerosis (SSc) patients at risk for scleroderma renal crisis. Comput Biol Med. 2014;53:203\u20135. https:\/\/doi.org\/10.1016\/j.compbiomed.2014.07.022.","journal-title":"Comput Biol Med"},{"issue":"2","key":"209_CR10","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1177\/2397198318823951","volume":"4","author":"A Fern\u00e1ndez-Codina","year":"2019","unstructured":"Fern\u00e1ndez-Codina A, Ca\u00f1as-Ruano E, Pope JE. Management of Raynaud's phenomenon in systemic sclerosis\u2014a practical approach. J Scleroderma Relat Disord. 2019;4(2):102\u201310. https:\/\/doi.org\/10.1177\/2397198318823951.","journal-title":"J Scleroderma Relat Disord"},{"issue":"3","key":"209_CR11","doi-asserted-by":"publisher","first-page":"134","DOI":"10.1038\/nrrheum.2016.212","volume":"13","author":"JE Pope","year":"2017","unstructured":"Pope JE. Connective tissue disease: reflections on the EULAR recommendations for the treatment of systemic sclerosis. Nat Rev Rheumatol. 2017;13(3):134\u20136. https:\/\/doi.org\/10.1038\/nrrheum.2016.212.","journal-title":"Nat Rev Rheumatol"},{"issue":"8","key":"209_CR12","doi-asserted-by":"publisher","first-page":"2246","DOI":"10.1002\/art.11073","volume":"48","author":"MD Mayes","year":"2003","unstructured":"Mayes MD, Lacey JV Jr, Beebe-Dimmer J, Gillespie BW, Cooper B, Laing TJ, et al. Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population. Arthritis Rheum. 2003;48(8):2246\u201355. https:\/\/doi.org\/10.1002\/art.11073.","journal-title":"Arthritis Rheum"},{"issue":"8","key":"209_CR13","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/j.autrev.2018.02.008","volume":"17","author":"S Panopoulos","year":"2018","unstructured":"Panopoulos S, Bournia VK, Konstantonis G, Fragiadaki K, Sfikakis PP, Tektonidou MG. Predictors of morbidity and mortality in early systemic sclerosis: long-term follow-up data from a single-Centre inception cohort. Autoimmun Rev. 2018;17(8):816\u201320. https:\/\/doi.org\/10.1016\/j.autrev.2018.02.008.","journal-title":"Autoimmun Rev"},{"issue":"10","key":"209_CR14","doi-asserted-by":"publisher","first-page":"797","DOI":"10.3949\/ccjm.84a.17025","volume":"84","author":"SC Shapiro","year":"2017","unstructured":"Shapiro SC, Wigley FM. Treating Raynaud phenomenon: beyond staying warm. Cleve Clin J Med. 2017;84(10):797\u2013804. https:\/\/doi.org\/10.3949\/ccjm.84a.17025.","journal-title":"Cleve Clin J Med"},{"key":"209_CR15","doi-asserted-by":"publisher","unstructured":"Hughes M, Pauling JD, Armstrong-James L, Denton CP, Galdas P, Flurey C. Gender-related differences in systemic sclerosis. Autoimmun Rev. 2020;102494:1\u20137. https:\/\/doi.org\/10.1016\/j.autrev.2020.102494.","DOI":"10.1016\/j.autrev.2020.102494"},{"key":"209_CR16","doi-asserted-by":"publisher","unstructured":"Hughes M, Allanore Y, Chung L, Pauling JD, Denton CP. Matucci-Cerinic M. Raynaud phenomenon and digital ulcers in systemic sclerosis. Nat Rev Rheumatol. 2020:208\u201321. https:\/\/doi.org\/10.1038\/s41584-020-0386-4.","DOI":"10.1038\/s41584-020-0386-4"},{"issue":"4","key":"209_CR17","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.biopsych.2014.06.015","volume":"77","author":"A O'Donovan","year":"2015","unstructured":"O'Donovan A, Cohen BE, Seal KH, Bertenthal D, Margaretten M, Nishimi K, et al. Elevated risk for autoimmune disorders in Iraq and Afghanistan veterans with posttraumatic stress disorder. Biol Psychiatry. 2015;77(4):365\u201374. https:\/\/doi.org\/10.1016\/j.biopsych.2014.06.015.","journal-title":"Biol Psychiatry"},{"issue":"7","key":"209_CR18","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1111\/j.1526-4637.2009.00714.x","volume":"10","author":"SG Haskell","year":"2009","unstructured":"Haskell SG, Brandt CA, Krebs EE, Skanderson M, Kerns RD, Goulet JL. Pain among veterans of operations enduring freedom and Iraqi freedom: do women and men differ? Pain Med. 2009;10(7):1167\u201373. https:\/\/doi.org\/10.1111\/j.1526-4637.2009.00714.x.","journal-title":"Pain Med"},{"issue":"2","key":"209_CR19","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1097\/AJP.0b013e318223d951","volume":"28","author":"SG Haskell","year":"2012","unstructured":"Haskell SG, Ning Y, Krebs E, Goulet J, Mattocks K, Kerns R, et al. Prevalence of painful musculoskeletal conditions in female and male veterans in 7 years after return from deployment in operation enduring freedom\/operation Iraqi freedom. Clin J Pain. 2012;28(2):163\u20137. https:\/\/doi.org\/10.1097\/AJP.0b013e318223d951.","journal-title":"Clin J Pain"},{"issue":"6","key":"209_CR20","first-page":"436","volume":"21","author":"J Bretza","year":"1979","unstructured":"Bretza J, Goldman JA. Scleroderma simulating vinyl chloride disease. J Occup Med. 1979;21(6):436\u20138.","journal-title":"J Occup Med"},{"issue":"3","key":"209_CR21","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/0049-0172(82)90055-5","volume":"11","author":"DC Haynes","year":"1982","unstructured":"Haynes DC, Gershwin ME. The immunopathology of progressive systemic sclerosis (PSS). Semin Arthritis Rheum. 1982;11(3):331\u201351. https:\/\/doi.org\/10.1016\/0049-0172(82)90055-5.","journal-title":"Semin Arthritis Rheum"},{"issue":"8314\u20135","key":"209_CR22","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/s0140-6736(83)91578-7","volume":"1","author":"CM Black","year":"1983","unstructured":"Black CM, Welsh KI, Walker AE, Bernstein RM, Catoggio LJ, McGregor AR, et al. Genetic susceptibility to scleroderma-like syndrome induced by vinyl chloride. Lancet. 1983;1(8314\u20135):53\u20135. https:\/\/doi.org\/10.1016\/s0140-6736(83)91578-7.","journal-title":"Lancet."},{"issue":"3","key":"209_CR23","doi-asserted-by":"publisher","first-page":"189","DOI":"10.3109\/08830189109061774","volume":"7","author":"R Mayer","year":"1991","unstructured":"Mayer R, Stone K, Han A, Bona C. Malignant CD5 B cells--biased immunoglobulin variable gene usage and autoantibody production. Int Rev Immunol. 1991;7(3):189\u2013203. https:\/\/doi.org\/10.3109\/08830189109061774.","journal-title":"Int Rev Immunol"},{"issue":"12","key":"209_CR24","first-page":"2395","volume":"31","author":"A Maitre","year":"2004","unstructured":"Maitre A, Hours M, Bonneterre V, Arnaud J, Arslan MT, Carpentier P, et al. Systemic sclerosis and occupational risk factors: role of solvents and cleaning products. J Rheumatol. 2004;31(12):2395\u2013401.","journal-title":"J Rheumatol"},{"key":"209_CR25","doi-asserted-by":"crossref","unstructured":"Ebel AV, Lutt G, Poole JA, Thiele GM, Baker JF, Cannon GW, et al. Association of Agricultural, Occupational, and Military Inhalants with Autoantibodies and Disease Features in U.S. Veterans with Rheumatoid Arthritis. Arthritis Rheumatol. 2020.","DOI":"10.1002\/art.41559"},{"issue":"2","key":"209_CR26","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.autrev.2013.10.002","volume":"13","author":"I Marie","year":"2014","unstructured":"Marie I, Gehanno JF, Bubenheim M, Duval-Modeste AB, Joly P, Dominique S, et al. Prospective study to evaluate the association between systemic sclerosis and occupational exposure and review of the literature. Autoimmun Rev. 2014;13(2):151\u20136. https:\/\/doi.org\/10.1016\/j.autrev.2013.10.002.","journal-title":"Autoimmun Rev"},{"key":"209_CR27","doi-asserted-by":"publisher","first-page":"590845","DOI":"10.1155\/2012\/590845","volume":"2012","author":"TM Frech","year":"2012","unstructured":"Frech TM, Penrod J, Battistone MJ, Sawitzke AD, Stults BM. The prevalence and clinical correlates of an auscultatory gap in systemic sclerosis patients. Int J Rheumatol. 2012;2012:590845.","journal-title":"Int J Rheumatol"},{"issue":"1","key":"209_CR28","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s11136-016-1370-y","volume":"26","author":"EL Merz","year":"2017","unstructured":"Merz EL, Malcarne VL, Roesch SC, Nair DK, Salazar G, Assassi S, et al. Longitudinal patterns of pain in patients with diffuse and limited systemic sclerosis: integrating medical, psychological, and social characteristics. Qual Life Res. 2017;26(1):85\u201394. https:\/\/doi.org\/10.1007\/s11136-016-1370-y.","journal-title":"Qual Life Res"}],"container-title":["BMC Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41927-021-00209-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41927-021-00209-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41927-021-00209-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,10,15]],"date-time":"2021-10-15T09:46:05Z","timestamp":1634291165000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcrheumatol.biomedcentral.com\/articles\/10.1186\/s41927-021-00209-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,15]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["209"],"URL":"https:\/\/doi.org\/10.1186\/s41927-021-00209-z","relation":{},"ISSN":["2520-1026"],"issn-type":[{"value":"2520-1026","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,15]]},"assertion":[{"value":"17 January 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"15 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Administrative permissions were required to access the raw data mentioned in the methods. The project has ethics approval through the VAMC IRB. The data was anonymized prior to use.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The approval for use of deidentified data did not require individual patient consent.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"42"}}